Skye Bioscience, Inc. (SKYE)

Skye Bioscience, Inc. (SKYE) is a healthcare company (biotechnology) based in the United States. The share price is $1.00, down 6.10% on the day, which values the company at $4.42M. Price as of 17 Nov 2026, 23:34 UTC, from Yahoo Finance.

Key facts

Share price
$1.00−6.10% today
Market value
$4.42M
200-week average
$30.1397% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Skye Bioscience, Inc. in more detail

SKYE trades at -0.2× next year's expected earnings. It sits 97% below its 200-week average of $30.13.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

1 of the superinvestors tracked here hold SKYE, including Julian and Felix Baker (0.0% of the portfolio).

Superinvestors holding SKYE

1 of the investors tracked here report a position in their latest 13F filing.

Skye Bioscience, Inc. (SKYE): questions and answers

What is Skye Bioscience, Inc.'s market cap?

Skye Bioscience, Inc. is valued at $4.42M at a share price of $1.00.

Is SKYE above its 200-week moving average?

No. SKYE is 96.7% below its 200-week average of $30.13. Long-term investors watch that line because strong companies rarely trade below it for long.

Does SKYE pay a dividend?

Skye Bioscience, Inc. does not currently pay a regular dividend.

Which famous investors own SKYE?

In their latest quarterly filings, Julian and Felix Baker (0.0% of the portfolio) hold SKYE. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Skye Bioscience, Inc. (SKYE) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/SKYE

Underlying data: Yahoo Finance; company filings with the SEC.